Amebiasis is a disease that affects the digestive system and is caused by a microscopic parasite called Entamoeba histolytica. It is usually transmitted through contact with human feces. Some individuals may not show symptoms, but the infection can cause diarrhea, nausea, weight loss, and fever. Approximately 10% of the world’s population is estimated to be affected by amebiasis, particularly in regions such as Mexico, India, Central and South America, Africa, and tropical areas of Asia. In industrialized countries, amebiasis is common among recent immigrants and travelers returning from regions where the parasite is widespread. Amebiasis can significantly impact nutrition and health.
Amebiasis occurs when the Entamoeba histolytica parasite enters the body and feeds on nutrients. The parasite's eggs mature into cysts inside the intestines and are expelled through feces. The infection spreads when individuals are exposed to small amounts of contaminated feces.
Amebiasis can be more severe in specific groups, including:
However, anyone can contract amebiasis in areas with poor sanitation. Risk factors include:
Amebiasis is a contagious disease transmitted when Entamoeba histolytica enters the digestive system through:
Some individuals can carry the parasite without showing symptoms but can still spread it through their feces, increasing the risk of infecting others.
Symptoms usually appear within months of infection and include:
Not all infected individuals exhibit symptoms, as Entamoeba histolytica can live in the intestines for long periods without causing noticeable effects.
Amebiasis is typically diagnosed by examining stool samples under a microscope. In severe cases where the infection spreads to the bloodstream, additional tests may be recommended, such as:
Non-harmful amebas can live in the intestines for years without causing symptoms. Invasive amebas causing amebic dysentery can result in episodes lasting from a few days to several weeks. Treatment includes nitroimidazole medications like metronidazole or tinidazole to target amebas in the blood, intestinal walls, and liver abscesses.
Asymptomatic individuals can be treated with intestinal medications alone to clear the infection. Reinfection can occur in high-risk areas, and in children, particularly in developing countries, amebiasis can be fatal, making it the third leading cause of death from parasitic infections globally.
While no vaccine is available for amebiasis, certain precautions can reduce the risk of infection, particularly in areas with poor sanitation:
Amebiasis significantly affects nutrition, particularly in malnourished individuals. The infection leads to diarrhea, abdominal pain, and poor nutrient absorption, exacerbating malnutrition. Severe cases can result in intestinal damage, impairing the absorption of essential nutrients such as proteins, vitamins, and minerals. The immune response to the infection increases the body's energy demands, further worsening nutritional status.
In vulnerable groups, particularly children, amebiasis can cause weight loss, stunted growth, and weakened immunity, increasing susceptibility to other infections. Proper nutrition is critical for recovery and supporting the body's ability to fight the infection.
References: